NDC 80425-0227-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0227
- Requested NDC
- 80425-0227-01
- Package NDCs from labels
- 80425-0227-1, 80425-0227-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0227-1 | Ondansetron | 10 in 1 BOTTLE, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0227 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, Legacy NDC, 1 package rows | 20250102_f1a0cd50-aa4f-55bc-e053-2995a90a2d3a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0227-1 | EA - Each | 80425-0227 | 6b0b97f9-0549-4145-81d9-0939a1e667a5 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | 2d1b8953-7ff5-4e91-ba97-3ba5c6ea8f71 | 2024-08-27 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Bryant Ranch Prepack | 8585e68b-965f-4f95-a5df-eea023cd5f82 | 2024-08-21 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Bryant Ranch Prepack | 3aeb533a-e72c-4af8-9867-b71d2eba9a49 | 2024-08-20 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| ondansetron | ONDANSETRON HYDROCHLORIDE | Sagent Pharmaceuticals | ba0f8f13-1f7d-44e0-9c0f-0b43a9e8e3a7 | 2024-08-15 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | d9321ef6-9fe5-4631-9c58-534fd963cf17 | 2024-08-08 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | 146b21e6-f8a5-47eb-b2d9-9ed70d1501d9 | 2024-08-08 | Warnings, Adverse reactions | ANDA078152 104894 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Bryant Ranch Prepack | 115e8fb5-61f5-4719-8eb3-063b7ca194ae | 2024-08-08 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | b297c163-2052-cb22-e053-2995a90a8289 | 2024-07-17 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Bryant Ranch Prepack | d6694136-7591-4f23-8415-f2aa3c8bab40 | 2024-07-16 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 8cea2f3a-cfa5-4a68-9ff4-b5a5a2085d08 | 2024-06-25 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Chartwell RX, LLC | 4c74336c-11ec-420a-80e1-d8e4a8f1c46d | 2024-06-24 | Warnings, Adverse reactions | 312087 104894 4AF302ESOS |
| ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | a1dd7420-dd81-2c8e-e053-2995a90ac8e6 | 2024-06-20 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 1b406d22-f1bf-460d-e063-6294a90a6b6f | 2024-06-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | 8f9fc8a2-0cfd-12f1-e053-2995a90acf3d | 2024-06-19 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 91bfbc0e-86a3-8ac6-e053-2a95a90af432 | 2024-06-19 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | NUCARE PHARMACEUTICALS INC | 8d696b8c-eba6-505e-e053-2995a90acb5d | 2024-06-18 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | 85cd0c27-788d-5fd8-e053-2a91aa0a7c69 | 2024-06-14 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | 87fd7e8e-fd04-34ad-e053-2a95a90a236d | 2024-06-14 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 7f315229-7e8f-67fd-e053-2a91aa0a8cb6 | 2024-06-12 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | NuCare Pharmceuticals,Inc. | 67395789-0ac7-2244-e053-2a91aa0a652a | 2024-06-07 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.